A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors

Clinical trial NCT03000257 · COMPLETED

Trial details

NCT number: NCT03000257
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2016-12-14
Primary completion: 2022-03-29
Enrollment: 182

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.